Fonseca, Pandora Eloa Oliveira, et al. “Benefits of Using SLGT2 Inhibitors for Patients With CDK and DM2 to Reduce Mortality Risks”. Archives of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 1, May 2024, pp. 041-6, doi:10.29328/journal.apps.1001055.